Troponins and natriuretic peptides in the monitoring of anthracycline cardiotoxicity

被引：38

作者：

Germanakis, Ioannis ^{[1
]}

Anagnostatou, Nikol ^{[2
]}

Kalmanti, Maria ^{[2
]}

机构：

[1] Univ Hosp Heraklion, Dept Pediat, Pediat Cardiol Unit, Iraklion, Greece

[2] Univ Hosp Heraklion, Dept Pediat Hematol Oncol, Iraklion, Greece

来源：

PEDIATRIC BLOOD & CANCER | 2008年 / 51卷 / 03期

关键词：

biological markers; cardiotoxicity after cancer therapy; diagnostic tools; late effects; natriuretic peptides; troponin;

D O I：

10.1002/pbc.21633

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Anthracycline-related cardiotoxicity has a substantial negative impact on long-term survivors of childhood cancer. The detection of cardiotoxicity is currently based on echocardiography or radionuclide angiography. However, as they depict only the final outcome of myocardial injury in terms of reduced heart contractility, heart specific biomarkers of myocardial destruction or dysfunction could be advantageous by allowing for an earlier detection of cardiotoxicity. In the present study, the usefulness of cardiac troponins and natriuretic peptides, the most commonly used biomarkers of myocardial destruction and ventricular dysfunction respectively, to detect and to predict the development of anthracycline cardiotoxicity has been reviewed.

引用

页码：327 / 333

页数：7

共 66 条

[1] B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children [J].

Aggarwal, Sanjeev ;

Pettersen, Michael D. ;

Bhambhani, Kanta ;

Gurczynski, Joellyn ;

Thomas, Ronald ;

L'Ecuyer, Thomas .

PEDIATRIC BLOOD & CANCER, 2007, 49 (06) :812-816

[2] National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biomarkers of heart failure [J].

Apple, Fred S. ;

Wu, Alan H. B. ;

Jaffe, Allan S. ;

Panteghini, Mauro ;

Christenson, Robert H. ;

Apple, Fred S. ;

Cannon, Christopher P. ;

Francis, Gary ;

Jesse, Robert L. ;

Morrow, David A. ;

Newby, L. Kristen ;

Storrow, Alan B. ;

Tang, W. H. Wilson ;

Wu, Alan H. B. ;

Apple, Fred S. ;

Christenson, Robert H. ;

Jaffe, Allan S. ;

Pagani, Franca ;

Tate, Jillian ;

Ordonez-Llanos, Jordi ;

Mair, Johannes .

CIRCULATION, 2007, 116 (05) :E95-E98

[3]

Apple Fred S, 2007, Circulation, V115, pe352

[4] Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies [J].

Auner, HW ;

Tinchon, C ;

Linkesch, W ;

Tiran, A ;

Quehenberger, F ;

Link, H ;

Sill, H .

ANNALS OF HEMATOLOGY, 2003, 82 (04) :218-222

[5]

BAUCH M, 1992, CANCER, V69, P1492, DOI 10.1002/1097-0142(19920315)69:6<1492::AID-CNCR2820690630>3.0.CO

[6]

2-3

[7] Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) study [J].

Blankenberg, Stefan ;

McQueen, Matthew J. ;

Smieja, Marek ;

Pogue, Janice ;

Balion, Cynthia ;

Lonn, Eva ;

Rupprecht, Hans J. ;

Bickel, Christoph ;

Tiret, Laurence ;

Cambien, Francois ;

Gerstein, Hertzel ;

Muenzel, Thomas ;

Yusuf, Salim .

CIRCULATION, 2006, 114 (03) :201-208

[8] THE IMPACT OF CHILDHOOD-CANCER ON THE UNITED-STATES AND THE WORLD [J].

BLEYER, WA .

CA-A CANCER JOURNAL FOR CLINICIANS, 1990, 40 (06) :355-367

[9] Use of cardiac markers to assess the toxic effects of anthracyclines given to children with cancer: A systematic review [J].

Bryant, J. ;

Picot, J. ;

Baxter, L. ;

Levitt, G. ;

Sullivan, I. ;

Clegg, A. .

EUROPEAN JOURNAL OF CANCER, 2007, 43 (13) :1959-1966

[10] ATRIAL-NATRIURETIC-PEPTIDE ELEVATION IN CONGESTIVE-HEART-FAILURE IN THE HUMAN [J].

BURNETT, JC ;

KAO, PC ;

HU, DC ;

HESER, DW ;

HEUBLEIN, D ;

GRANGER, JP ;

OPGENORTH, TJ ;

REEDER, GS .

SCIENCE, 1986, 231 (4742) :1145-1147

← 1 2 3 4 5 6 7 →